|
C6ORF89 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28259999996072E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.0484999999979E-05 |
| Normal-vs-Stage2 |
2.961100E-03 |
| Normal-vs-Stage3 |
2.969800E-04 |
| Normal-vs-Stage4 |
7.944200E-03 |
| Stage1-vs-Stage2 |
8.893000E-01 |
| Stage1-vs-Stage3 |
3.011600E-01 |
| Stage1-vs-Stage4 |
2.790800E-01 |
| Stage2-vs-Stage3 |
3.098200E-01 |
| Stage2-vs-Stage4 |
1.897620E-01 |
| Stage3-vs-Stage4 |
6.708600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.67589999997298E-06 |
| Normal-vs-AfricanAmerican |
1.197320E-03 |
| Normal-vs-Asian |
1.113990E-01 |
| Caucasian-vs-AfricanAmerican |
7.146400E-01 |
| Caucasian-vs-Asian |
6.646000E-01 |
| AfricanAmerican-vs-Asian |
5.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.23149999992678E-07 |
| Normal-vs-Female |
3.640400E-02 |
| Male-vs-Female |
6.917800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.246620E-04 |
| Normal-vs-Extreme_Weight |
1.4312999999655E-06 |
| Normal-vs-Obese |
7.478700E-03 |
| Normal-vs-Extreme_Obese |
1.709540E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.160000E-01 |
| Normal_Weight-vs-Obese |
1.260820E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.020800E-01 |
| Extreme_Weight-vs-Obese |
6.688100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.782200E-01 |
| Obese-vs-Extreme_Obese |
8.063800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.843000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.144700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.69550000495411E-08 |
| Normal-vs-Age(81-100Yrs) |
5.620900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.772400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.084450E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.509500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.201600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.253800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.518900E-03 |
| Normal-VS-Type2 PRCC |
1.24569998760649E-09 |
| Normal-VS-KIRP CIMP |
6.416400E-01 |
| Normal-VS-Unclassified PRCC |
5.765700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.74979999999892E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.494000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.186000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.980300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.035610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.359000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.16620004950863E-09 |
| Normal-vs-N1 |
8.286100E-02 |
| Normal-vs-N2 |
1.805000E-04 |
| N0-vs-N1 |
1.748850E-01 |
| N0-vs-N2 |
5.110000E-01 |
| N1-vs-N2 |
3.667700E-02 |
|
|
